Article | May 20, 2016

Avoiding Collaboration Failure In Bio Pharma: Is It Possible? With The Cloud It Is.

Source: Dassault Systemes Americas

By Matt Hahn, Ph.D., senior VP and CTO, Dassault Systèmes BIOVIA

With the drug patent cliff continuing to cast a long shadow over biopharma, the industry is radically reinventing itself by embracing globalization and focusing on innovation and operational excellence. Most importantly, biopharma organizations are expanding externalized collaborative relationships beyond traditional boundaries and creating flexible networks of researchers — some in-house, others with industry and academic partners, research institutes and contract research organizations. These networks are increasing in size and complexity with many combining numerous partners with diverse project objectives. Externalized projects like this raise important data security and project management challenges.